Schedule 13D ownership disclosure

ASSEMBLY BIOSCIENCES INC

Common Stock, par value $0.001 · CUSIP: 045396108

Event date: 2024-12-19

Filing-level shares
2,209,471.00
Percent of class
29.9%
  • Gilead Sciences, Inc.Reported CIK 0000882095

    Shares: 2,209,471.00 · Class: 29.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000904454-24-000667
Form type
SCHEDULE 13D/A
Filer
ASSEMBLY BIOSCIENCES, INC.
CIK
CIK 1426800
Filed
Dec 23, 2024
Reporting period
Dec 19, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub